International Journal of Drug Delivery Technology
Volume 14, Issue 2

Development and Characterization of Olmesartan Medoxomil-Loaded Microspheres for Hypertension Management

Dipak Mali1*, Sandip Bandgar2, Indrayani Bandgar3, Dinanath Gaikwad4

1Department of Pharmaceutical Quality Assurance, Krishna Institute of Pharmacy, Krishna Vishwa Vidyapeeth (Deemed to be University), Karad, Maharashtra, India.

2Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgoan, Maharashtra, India.

3Department of Pharmaceutics, Rajarambapu College of Pharmacy, Kasegaon, Maharashtra, India.

4Department of Pharmaceutics, Bharati Vidyapeeth College of Pharmacy, Kolhapur, Maharashtra, India. 

Received: 09th May, 2024; Revised: 25th May, 2024; Accepted: 05th June, 2024; Available Online: 25th June, 2024 

ABSTRACT

Our aim is to develop and assess microspheres loaded with olmesartan medoxomil, the antagonist of angiotensin II receptor which is used in hypertension treatment, for their efficacy. The microspheres were fabricated through a solvent evaporation process employing eudragit L100 and chitosan as the inner phase and liquid paraffin as the outer phase. Optimization was done according to the results of entrapment efficiency and in-vitro drug release. Fourier-transform infrared (FTIR) analysis indicated negligible interaction, which clarifies the suitability of the drug and excipients. The resulting microspheres exhibited a pale yellow hue and free-flowing characteristics, as confirmed by micromeritics experiments. Scanning electron microscopy (SEM) revealed smooth and spherical microspheres. Particle size, ranging from 187.44 to 358.75 µm, increased with polymer concentration, as determined by optical microscopy. Formulation F9, with a ratio of eudragit L100 to chitosan at 7:1, demonstrated the highest drug entrapment percentage (97.82%). In-vitro release studies demonstrated a reduction in olmesartan medoxomil release with increasing polymer content, with formulation F9 sustaining release for 12 hours. Furthermore, short-term accelerated stability testing indicated the physicochemical stability of the microsphere formulations throughout the stability period.

Keywords: Olmesartan medoxomil, Microspheres, Solvent evaporation, Eudragit L100, Chitosan. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.2.61

How to cite this article: Mali D, Bandgar S, Bandgar I, Gaikwad D. Development and Characterization of Olmesartan Medoxomil-Loaded Microspheres for Hypertension Management. International Journal of Drug Delivery Technology. 2024;14(2):1004-1010.

REFERENCES

  1. Ball KJ, Williams PA, Stumpe KO. Relative efficacy of an angiotensin II antagonist compared with other antihypertensive agents. Olmesartan medoxomil versus antihypertensives. J Hypertens Suppl. 2001;19(1):S49-S56.
  2. Neutel JM, Elliott WJ, Izzo JL, Chen CL, Masonson HN. Antihypertensive efficacy of Olmesartan medoxomil, a new angiotensin II receptor antagonist, as assessed by ambulatory blood pressure J Clin Hypertens. 2002;4(5):325- 331.
  3. Norwood D, Branch E, Smith B, Honeywell M. Olmesartan medoxomil for hypertension: A clinical review. Drug Forecast. 2002;27(12):611-618.
  4. Venkatesan P, Manavalan R, Valliappan Microencapsulation: a vital technique in novel drug delivery system. J Pharma Sci Res. 2009;1(4):26-35.
  5. Sahil K, Akanksha M, Premjeet S, Bilandi A, Kapoor Microsphere: A review. Int J Res Pharm Chem. 2011;1(4):2231- 2281.
  6. Wong CY, Al-Salami H, Dass Microparticles, microcapsules and microspheres: A review of recent developments and prospects for oral delivery of insulin. Int J Pharm. 2018;537(1-2):223-244.
  7. Kumar A, Mahajan S, Bhandari N. Microspheres: A review. World J Pharm Pharma Sci. 2017;6(4):724-740.
  8. Nanjwade VK, Manvi FV, Nanjwade BK. Formulation and evaluation of dispersible tablets of Lomefloxacin Int J Drug Dev Res. 2013;5(1):103-113.
  9. Reddy SK, Khan KA, Nagaraja A review on the determination of melting point measurement system. Int J Adv Res Elec Electro Ins Eng. 2016;5(2):975-979.
  10. Yuksel N, Baykara Preparation of Polymeric microspheres by the solvent evaporation method using sucrose stearate as a droplet stabilizer. J Microencapsulation. 1997;14(6):725-733.
  11. Asif HM, Kumar RA, Rao TR, Anjum M. Preparation and evaluation of ethylcellulose microspheres prepared by solvent evaporation Int J Pharm Pharm Sci. 2014;6(7):264-266.
  12. Murtaza G, Ahmad A, Waheed AA, Naeem AM. Salbutamol sulphate-ethylcellulose microparticles: Formulation and in-vitro evaluation with emphasis on mathematical approaches. Daru. 2009;17(3):209-216.
  13. Yogesh ST, Vinayak SM, Shashikant CD. Use of carbomers to design mucoadhesive microspheres for an anti H. pylori drug, clarithromycin. Int J Pharm Tech Res. 2009;1(4):1421-1428.
  14. Gera S, Cheruvu S, Zakkula A, Sampathi S. Synthesis and evaluation of Olmesartan medoxomil complex with SBE7 β-CD for enhanced dissolution and Int J Pharm Pharma Sci. 2015;8(1):333-343.
  15. Nighute AB, Bhise Preparation and evaluation of Rifabutin loaded polymeric microspheres. Res J Pharm Tech. 2009;2(2):371-374.
  16. Bansal H, Kaur SP, Gupta AK. Microsphere: Methods of preparation and applications: A comparative study. Int J Pharm Sci Rev Res. 2011;10(1):69-78.
  17. Mali DP, Kamble SP, Gaikwad DT, Wadkar GH, Bhutkar MA, Tamboli FA, Pawar Standardization and evaluation of herbal antihypertensive sarpagandha (reserpine) tablet formulations. International Journal of Pharmaceutical Quality Assurance. 2023;14(1):7-14
  18. Tamboli FA, Gaikwad DT, Salunkhe AA. Elevating herbal therapies: A deep dive into International Journal of Pharmaceutical Quality Assurance. 2024;15(1):515-522.
  19. Patil A, Tamboli F, Gaikwad D, Mudalkar P, Alaskar K. Formulation and evaluation of probiotics properties of lactobacillus with antimicrobial activities. International Journal of Drug Delivery Technology. 2023;13(2):522-528.
  20. Jadhav KK, Gangadharappa HV. Formulation and evaluation of microspheres drug delivery for multiple sclerosis disease condition. International Journal of Drug Delivery Technology. 2024;14(1):79-93.